Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination
Ramona Mögling, Adam Meijer, Nataša Berginc, Sylvia M. Bruisten, Rémi N. Charrel, Bruno Coutard, Isabella Eckerle, Vincent Enouf, Olav Hungnes, Gülay Korukluoğlu, Thanos Kossyvakis, Αndreas Mentis, Richard Molenkamp, Shaman Muradrasoli, Anna Papa, Fiona Pigny, Laurence Thirion, Sylvie van der Werf, Chantal Reusken
Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Contamination2019-20 coronavirus outbreakMolecular diagnosticsCoronavirusVirologyBetacoronavirusDiagnostic testMedicinePrimer (cosmetics)Infection controlBiologyIntensive care medicineVeterinary medicineOutbreakPathologyBioinformaticsChemistryOrganic chemistryEcologyInfectious disease (medical specialty)DiseaseSARS-CoV-2 detection and testingBiosensors and Analytical DetectionSARS-CoV-2 and COVID-19 Research